You are here: Industry Insights > Parkinson’s disease

News List

Are scientists homing in on a cure for Parkinson’s disease? WorldPharmaNews
December 13, 2021
A molecule that shows promise in preventing Parkinson’s disease has been refined by scientists at the University of Bath in the UK, and has the potential to be developed into a drug to treat the deadly neurodegenerative disease.
UCB and Novartis to co-develop two drug candidates for Parkinson’s Disease Pharmaceutical-Technology
December 06, 2021
Belgian pharmaceutical firm UCB has signed an agreement with Novartis to develop disease-modifying treatments for Parkinson’s Disease (PD) patients.
Eisai and Wren Therapeutics to collaborate for drug discovery for synucleinopathies expresspharma
December 01, 2020
This collaboration aims to develop a disease modifying treatment for synucleinopathies based on network kinetics of α-synuclein misfolding and aggregation.
Supernus Provides Regulatory Updates for SPN-812 and SPN-830 americanpharmaceuticalreview
November 20, 2020
Supernus Pharmaceuticals announced regulatory updates for SPN-812 (viloxazine hydrochloride) for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients 6 to 17 years of age, and SPN-830 (apomorphine infusion pump) for ...
Adamas Announces FDA Filing Acceptance of sNDA to Modify Indication Statement for GOCOVRI americanpharmaceuticalreview
June 16, 2020
Adamas Pharmaceuticals announced its supplemental New Drug Application (sNDA) for GOCOVRI as a treatment for OFF episodes in Parkinson’s disease (PD) patients receiving levodopa-based therapy ...
Seelos Announces Initiation of Preclinical Study of SLS-004 in Parkinson’s Disease americanpharmaceuticalreview
June 04, 2020
Seelos Therapeutics announced the initiation of a preclinical study of SLS-004 in Parkinson’s disease (PD) through an all-in-one lentiviral vector targeting the synuclein alpha (SNCA) gene.
Sunovion gets FDA nod for Kynmobi to treat Parkinson’s disease off episodes pharmaceutical-business-review
May 27, 2020
Sunovion Pharmaceuticals has secured approval from the US Food and Drug Administration (FDA) for its Kynmobi (apomorphine hydrochloride) sublingual film (APL-130277) to treat Parkinson’s disease (PD) off episodes.
Stem cells used to replace neurons in patient with Parkinson’s disease europeanpharmaceuticalreview
May 20, 2020
A team has revealed that a patient who received induced pluripotent stem cells to replace lost dopaminergic neurons has reduced symptoms of Parkinson’s disease.
Adamas Announces Patent for GOCOVRI in Parkinson’s Disease americanpharmaceuticalreview
May 19, 2020
Adamas Pharmaceuticals has been issued a new patent (no. 10,646,456) by the United States Patent and Trademark Office (USPTO) that covers GOCOVRI® (amantadine) extended release capsules.
Researchers develop potential therapeutic model for Parkinson’s disease biospectrumasia
February 13, 2019
Stem cell technology finds its application in elucidating Parkinson's disease using patient-derived cells

Previous page 1 2 3 Next page